The pituitary gland and luteinizing hormone (LH) are central regulators of human reproduction, steroidogenesis, and endocrine balance. The pituitary, a small endocrine gland at the base of the brain, secretes LH in response to gonadotropin-releasing hormone (GnRH) from the hypothalamus. In turn, LH acts on the gonads to control ovulation, spermatogenesis, and the production of sex steroids such as estrogen and testosterone. Dysregulation at any level—hypothalamus, pituitary, or gonads—can alter LH patterns and lead to fertility issues, menstrual disorders, or symptoms of hypogonadism. This explainer clarifies normal function, how LH is measured and interpreted, common causes of abnormalities, and the clinical contexts in which LH testing and management are used.
What the Pituitary Gland Does
The pituitary gland is divided into two main functional parts: the anterior pituitary (adenohypophysis) and the posterior pituitary (neurohypophysis). The anterior pituitary synthesizes and secretes several hormones, including LH, follicle-stimulating hormone (FSH), thyroid-stimulating hormone (TSH), prolactin, growth hormone (GH), and adrenocorticotropic hormone (ACTH). These anterior pituitary hormones are released into the bloodstream and regulate other endocrine glands. The posterior pituitary stores and releases vasopressin (antidiuretic hormone, or ADH) and oxytocin, which are produced by hypothalamic neurons. The pituitary operates within a feedback network in which upstream signals from the hypothalamus and downstream signals from target glands modulate hormone production and secretion.
Luteinizing Hormone: Definition and Physiology
Luteinizing hormone is a glycoprotein hormone produced by gonadotroph cells in the anterior pituitary. Its secretion is primarily stimulated by GnRH pulses from the hypothalamus and is modulated by feedback from sex steroids (estrogen, progesterone, and testosterone) as well as inhibin. In women, the midcycle LH surge triggers ovulation and supports corpus luteum formation, leading to progesterone production. In men, LH stimulates Leydig cells in the testes to produce testosterone, which is necessary for spermatogenesis and the development of male secondary sexual characteristics. LH and FSH are often measured together to evaluate hypothalamic–pituitary–gonadal (HPG) axis function.
Pulsatility and Circadian Influences
GnRH secretion is pulsatile, which in turn drives pulsatile LH release. The frequency and amplitude of GnRH/LH pulses vary across the menstrual cycle, during puberty, and with aging. In conditions such as polycystic ovary syndrome (PCOS) or hypogonadotropic hypogonadism, these pulse patterns can be disrupted, contributing to anovulation or low testosterone. Circadian rhythms and factors such as sleep, stress, and energy balance also influence LH secretion, which is why single LH values are interpreted alongside clinical context and, when indicated, repeated or timed measurements.
How LH Is Measured and Interpreted
LH is typically measured in blood samples using immunoassays in clinical laboratories. Results are reported in international units per liter (IU/L). Reference ranges vary by assay, laboratory, age, sex, and menstrual cycle phase, so it is important to use the ranges provided by the specific laboratory and to interpret results in light of clinical findings. In premenopausal women, LH levels fluctuate during the menstrual cycle; early follicular phase levels are generally lower, with a pronounced midcycle peak. In postmenopausal women and men, LH is typically elevated when there is primary gonadal failure and low when the cause is central (hypothalamic or pituitary). Pediatric ranges differ, and timing within the menstrual cycle is essential for accurate interpretation in women of reproductive age.
Limitations and Preanalytical Factors
LH assays exhibit cross-reactivity with other glycoprotein hormones in some immunoassays, particularly when measuring very high concentrations. Heterophilic antibodies or certain medications can interfere with results, leading to falsely high or low values. Because LH secretion is pulsatile, random single values may not capture underlying pathology; dynamic testing or multiple measurements may be needed. For example, a GnRH stimulation test can assess pituitary responsiveness but is not routine for most initial evaluations. Menstrual cycle day or time of day can affect LH levels, and specific assay methodologies should be confirmed with the laboratory.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Hormone | Luteinizing hormone (LH) | Endocrine Society/Assay guidelines |
| Primary site of production | Anterior pituitary gonadotroph cells | Endocrine physiology references |
| Main stimulus for secretion | Pulsatile GnRH from hypothalamus | Endocrine physiology references |
| Key feedback inhibitors | Sex steroids (estrogen, progesterone, testosterone) and inhibin | Endocrine negative feedback models |
| Units of measurement | International units per liter (IU/L) | Assay standard reporting |
| Cycle-phase variation (women) | Follicular phase lower; midcycle LH surge triggers ovulation | Reproductive endocrinology data |
Common Causes of High LH
Elevated LH levels are often seen in conditions associated with gonadal failure or disrupted feedback. In women, menopause is characterized by high LH and FSH due to the loss of ovarian estrogen and inhibin feedback. Conditions such as primary ovarian insufficiency and polycystic ovary syndrome can also raise LH, particularly when androgen excess and anovulation are present. In men, primary testicular failure from genetic, infectious, or toxic causes leads to elevated LH as the pituitary attempts to stimulate testosterone production. Less commonly, impaired steroid signaling can result in elevated LH despite normal or high sex steroid levels (e.g., certain forms of hypogonadism). Interpretation should always consider clinical context, other hormone results, and ultrasound or genetic findings when available.
Common Causes of Low LH
Low LH levels typically indicate that the pituitary is not secreting adequate gonadotropins, or that upstream hypothalamic drive is reduced. Secondary causes include hypothalamic amenorrhea due to energy deficit, excessive exercise, or stress; pituitary disorders such as tumors, infiltrative disease, or prior surgery/radiation; and medications such as glucocorticoids or hormonal contraceptives that can suppress pulsatile GnRH. In men, low LH can contribute to low testosterone and impaired spermatogenesis, leading to symptoms such as reduced libido and infertility. Central causes of elevated gonadotropins (central precocious puberty) are rarer and usually accompanied by other clinical features. Because low LH can have diverse etiologies, evaluation often includes additional pituitary function tests and imaging when indicated.
Clinical Contexts and When to Test
LH testing is commonly included in infertility workups, assessments of amenorrhea or oligomenorrhea, evaluations of delayed or precocious puberty, and monitoring during assisted reproductive technology cycles. It is also used in the diagnosis and management of conditions such as PCOS, hypogonadism, and disorders of sexual development. Timing matters: in menstruating women, day 2–5 follicular-phase LH is often measured alongside FSH; the midcycle surge is usually not captured by random testing and may require serial measurements or urinary LH kits. In suspected central hypogonadism, provocative testing may be considered. Because interpretation is tightly linked to age, sex, menstrual status, and clinical presentation, clinicians typically integrate LH results with other hormonal assays and imaging rather than relying on a value in isolation.
Key Considerations and Limitations
- Assay variability: Different assays and laboratories report different reference intervals; always use the range provided by your laboratory.
- Pulsatile secretion: LH varies across the day and across the menstrual cycle; single random values may be misleading without appropriate context.
- Cycle timing: In women of reproductive age, menstrual cycle day is essential for meaningful interpretation.
- Medications and interference: Some drugs and antibodies can interfere with immunoassays; inform your clinician of relevant medications.
- Comprehensive evaluation: LH should be interpreted with FSH, sex steroids, and sometimes additional pituitary hormones and imaging.
Summary
The pituitary gland controls luteinizing hormone as part of a finely tuned feedback system involving the hypothalamus and gonads. LH drives ovulation in women and testosterone production in men, and its pattern of secretion reflects both central control and peripheral feedback. Abnormal LH levels can signal conditions such as menopause, primary gonadal failure, hypothalamic amenorrhea, or pituitary dysfunction. Because LH varies with menstrual cycle phase, age, and assay methodology, interpretation requires attention to clinical context, corroborating hormone results, and, when indicated, imaging or dynamic testing. Understanding the relationship between the pituitary gland and luteinizing hormone provides a durable framework for evaluating reproductive and endocrine health over time.